Nothing Special   »   [go: up one dir, main page]

GB201413538D0 - Ophthalmic compositions and uses thereof - Google Patents

Ophthalmic compositions and uses thereof

Info

Publication number
GB201413538D0
GB201413538D0 GBGB1413538.8A GB201413538A GB201413538D0 GB 201413538 D0 GB201413538 D0 GB 201413538D0 GB 201413538 A GB201413538 A GB 201413538A GB 201413538 D0 GB201413538 D0 GB 201413538D0
Authority
GB
United Kingdom
Prior art keywords
ophthalmic compositions
ophthalmic
compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1413538.8A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Quark Pharmaceuticals Inc
Original Assignee
Quark Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Quark Pharmaceuticals Inc filed Critical Quark Pharmaceuticals Inc
Priority to GBGB1413538.8A priority Critical patent/GB201413538D0/en
Publication of GB201413538D0 publication Critical patent/GB201413538D0/en
Ceased legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/55Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound the modifying agent being also a pharmacologically or therapeutically active agent, i.e. the entire conjugate being a codrug, i.e. a dimer, oligomer or polymer of pharmacologically or therapeutically active compounds
    • A61K47/551Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound the modifying agent being also a pharmacologically or therapeutically active agent, i.e. the entire conjugate being a codrug, i.e. a dimer, oligomer or polymer of pharmacologically or therapeutically active compounds one of the codrug's components being a vitamin, e.g. niacinamide, vitamin B3, cobalamin, vitamin B12, folate, vitamin A or retinoic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0048Eye, e.g. artificial tears

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Ophthalmology & Optometry (AREA)
GBGB1413538.8A 2014-07-30 2014-07-30 Ophthalmic compositions and uses thereof Ceased GB201413538D0 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GBGB1413538.8A GB201413538D0 (en) 2014-07-30 2014-07-30 Ophthalmic compositions and uses thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1413538.8A GB201413538D0 (en) 2014-07-30 2014-07-30 Ophthalmic compositions and uses thereof

Publications (1)

Publication Number Publication Date
GB201413538D0 true GB201413538D0 (en) 2014-09-10

Family

ID=51587497

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1413538.8A Ceased GB201413538D0 (en) 2014-07-30 2014-07-30 Ophthalmic compositions and uses thereof

Country Status (1)

Country Link
GB (1) GB201413538D0 (en)

Similar Documents

Publication Publication Date Title
IL249643A0 (en) Ophthalmic composition
GB2535253B (en) Compositions and methods
IL250568A0 (en) Anti-methanogenic compositions and uses thereof
HK1231471A1 (en) 6-heteroaryloxy- and 6-aryloxy-quinoline-2-carboxamides and uses thereof 6-- 6--2-
IL247262B (en) Cannabinoid compositions and uses
GB201411197D0 (en) Composition and use thereof
PL3018183T3 (en) Haloolefin-based composition and use thereof
GB2537078B (en) Settable compositions and uses thereof
PL3152226T3 (en) Modified cyclopentapeptides and uses thereof
GB201417828D0 (en) New methods and compositions
GB201401617D0 (en) Novel combination and use
HK1243950A1 (en) Novel combination and use
GB201619525D0 (en) Ophthalmic composition
GB201502002D0 (en) Uses and compositions
SG11201707117SA (en) Ophthalmic composition
GB201501991D0 (en) Uses and compositions
GB201502026D0 (en) Uses and compositions
GB201411196D0 (en) Composition and use thereof
IL248863A0 (en) Compositions comprising il-31 and uses thereof
GB201511886D0 (en) Uses and compositions
ZA201703701B (en) Ophthalmic composition
IL251590B (en) Ophthalmic compositions
PL3446682T3 (en) Ophthalmic composition
GB201522814D0 (en) Compositions and uses thereof
GB201402915D0 (en) Compositions and methods

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)